* MiMedx Group Inc MDXG.OQ reported a quarterly adjusted
loss
of 9 cents per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 8 cents per share.
* Revenue rose 7.3% to $67.69 million from a year ago;
analysts
expected $66.73 million.
* MiMedx Group Inc's reported EPS for the quarter was a loss
of 9
cents.
* The mean earnings estimate of analysts had fallen by
about 93.7%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* MiMedx Group Inc shares had risen by 5.2% this quarter and
lost 50.0% so far this year.
* The company reported a quarterly loss of $10.1 million.
* Wall Street's median 12-month price target for MiMedx
Group Inc
is $9.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
3 at 12:02 a.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.08 -0.09 Missed
Jun. 30 2022 -0.06 -0.11 Missed
Mar. 31 2022 -0.10 -0.11 Missed
Dec. 31 2021 -0.03 0.01 Beat